Palliative hormone therapy, low-dose chemotherapy, and bisphosphonate in breast cancer patients with bone marrow involvement and pancytopenia: report of a pilot experience
- 1 December 2000
- journal article
- research article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 11 (6) , 329-333
- https://doi.org/10.1016/s0953-6205(00)00121-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate TreatmentNew England Journal of Medicine, 1998
- The value of bone marrow biopsy in breast cancer at the time of first relapse.A prospective studyCancer, 1988
- The presence of tumor cells in bone marrow at the time of first recurrence of breast cancerCancer, 1987
- Multivariate analysis of prognostic factors in metastatic breast cancer.Journal of Clinical Oncology, 1983
- Prognostic value of bone marrow biopsy in breast cancerCancer, 1982
- Combination chemotherapy for breast cancer metastatic to bone marrowCancer, 1981
- Combination chemotherapy for thrombocytopenia with bone marrow metastases from breast cancer.BMJ, 1977
- Bone marrow involvement in breast cancer.Effect on response and tolerance to combination chemotherapyCancer, 1977
- Value of the bone marrow biopsy in the diagnosis of metastatic carcinomaCancer, 1972